María de la Fuente

Maria de la Fuente Freire is a cofounder of DIVERSA since May 2021 and serves as the Head of the Nano-Oncology and Translational Therapeutics group at Servizo Galego de Saúde, where research focuses on developing new experimental therapies and diagnostic modalities in translational oncology. Maria has a rich academic background, having held positions such as Research Fellow at the University of Santiago de Compostela and Postdoctoral Researcher at UCL-School of Pharmacy, among others. Maria’s educational credentials include an Executive MBA from Esade and Galicia Business School, a high-level management program from IESE Business School, a PhD in Pharmaceutical Technology with a focus on Nanotechnology and Drug Delivery from Universidad de Santiago de Compostela, and a Licenciatura en Farmacia, specializing in clinical health.